<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02441426</url>
  </required_header>
  <id_info>
    <org_study_id>MAL-ED-47075</org_study_id>
    <nct_id>NCT02441426</nct_id>
  </id_info>
  <brief_title>Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development</brief_title>
  <acronym>MAL-ED</acronym>
  <official_title>Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Foundation for the National Institutes of Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Christian Medical College, Vellore, India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henry M. Jackson Foundation for the Advancement of Military Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health, Fogarty International Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Foundation for the National Institutes of Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malnutrition is considered one of the most prevalent risk factors for morbidity and mortality
      in children under five. An estimated 20% of children in the developing world are malnourished
      [1] and poor nutrition is linked to more than half of all child deaths worldwide [2].
      Malnutrition in early childhood may lead to cognitive and physical deficits and may cause
      similar deficits in future generations as malnourished mothers give birth to low birth weight
      children [3]. In addition, malnutrition increases susceptibility and incidence of infections
      and is associated with diminished response to vaccines.

      The MAL-ED Project is designed to determine the impact of enteric infections/diarrhea that
      alter gut function and impair children's nutrition, growth and development to help develop
      new intervention strategies that can break the vicious enteric infection-malnutrition cycle
      and reduce its global burden.

      The overall objective of the MAL-ED Project is to quantify the associations of specific
      enteric pathogens, measures of physical and mental development, micronutrient malnutrition,
      gut function biomarkers, the gut microbiome, and immune responses in very young children in
      resource-limited settings across eight sites that vary by culture, economics, geography, and
      climate.

      The central hypothesis of the MAL-ED Project is that infection (and co-infection) with
      specific enteropathogens leads to impaired growth and development and to diminished immune
      response to orally administered vaccines by causing intestinal inflammation and/or by
      altering intestinal barrier and absorptive function. Data analyses will test for associations
      between enteropathogen infections and growth/development to help illuminate:

        -  which micro-organisms or mixed infections are most frequently associated with growth
           faltering and poor development; and

        -  at what age specific infections cause the most disruption to growth and development and
           impair immune response.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diarrhea</measure>
    <time_frame>Each diarrheal episode willbe recorded for up to 24 months of age.</time_frame>
    <description>All diarrheal samples are analyzed for the presence of bacterial, viral, and parasitic pathogens. Normal stool is collected monthly and analyzed for the same list of 57 different pathogens.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometry</measure>
    <time_frame>Anthropomentry will be recorded each month for up to 24 months of age.</time_frame>
    <description>Head Circumference, length, and weight are measured monthly on the anniversary of the child's birth.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive development</measure>
    <time_frame>Cognitive development will be recorded at 6 months of age.</time_frame>
    <description>A battery of tests include the Bayley Scales of Infant Development, MacArthur Words and Gestures, Infant Temperament Scale, HOME inventory, SRQ-20 and Raven's Combined Progressive Matrices.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vaccine response</measure>
    <time_frame>Vaccine response will be recorded at 7 months of age.</time_frame>
    <description>Antibody titers will be determined following immunization against rotavirus, polio virus, tetanus toxoid, pertussis toxin and measles vaccines.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive development</measure>
    <time_frame>Cognitive development will be recorded at 8 months of age.</time_frame>
    <description>A battery of tests include the Bayley Scales of Infant Development, MacArthur Words and Gestures, Infant Temperament Scale, HOME inventory, SRQ-20 and Raven's Combined Progressive Matrices.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive development</measure>
    <time_frame>Cognitive development will be recorded at 15 months of age.</time_frame>
    <description>A battery of tests include the Bayley Scales of Infant Development, MacArthur Words and Gestures, Infant Temperament Scale, HOME inventory, SRQ-20 and Raven's Combined Progressive Matrices.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vaccine response</measure>
    <time_frame>Vaccine response will be recorded at 15 months of age.</time_frame>
    <description>Antibody titers will be determined following immunization against rotavirus, polio virus, tetanus toxoid, pertussis toxin and measles vaccines.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive development</measure>
    <time_frame>Cognitive development will be recorded 24 months of age.</time_frame>
    <description>A battery of tests include the Bayley Scales of Infant Development, MacArthur Words and Gestures, Infant Temperament Scale, HOME inventory, SRQ-20 and Raven's Combined Progressive Matrices.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vaccine response</measure>
    <time_frame>Vaccine response will be recorded at 24 months of age.</time_frame>
    <description>Antibody titers will be determined following immunization against rotavirus, polio virus, tetanus toxoid, pertussis toxin and measles vaccines.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gut inflammation</measure>
    <time_frame>Gut inflammation will be recorded each month for up to 24 months of age.</time_frame>
    <description>Stool biomarkers will be evaluated to detect gut and systemic inflammation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut integrity</measure>
    <time_frame>Gut integritywill be recorded at at 3 months of age.</time_frame>
    <description>Intestinal absorptive capacity and barrier function will be assessed by dual sugar permeability test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut integrity</measure>
    <time_frame>Gut integritywill be recorded at at 6 months of age.</time_frame>
    <description>Intestinal absorptive capacity and barrier function will be assessed by dual sugar permeability test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut integrity</measure>
    <time_frame>Gut integritywill be recorded at at 9 months of age.</time_frame>
    <description>Intestinal absorptive capacity and barrier function will be assessed by dual sugar permeability test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut integrity</measure>
    <time_frame>Gut integritywill be recorded at at 15 months of age.</time_frame>
    <description>Intestinal absorptive capacity and barrier function will be assessed by dual sugar permeability test.</description>
  </secondary_outcome>
  <number_of_groups>8</number_of_groups>
  <enrollment type="Anticipated">1796</enrollment>
  <condition>Diarrhea</condition>
  <condition>Malnutrition</condition>
  <condition>Stunting</condition>
  <condition>Wasting</condition>
  <condition>Immune Response</condition>
  <condition>Cognitive Development</condition>
  <arm_group>
    <arm_group_label>Bangladesh</arm_group_label>
    <description>Birth cohort study community in Bangladesh is urban, and located in the Mirpur neighborhood of Dhaka.
Case control study is being conducted in the same catchment area. Cases defined as children 6-24 months of age with &lt;-2WAZ (weight for age) score, controls are age and community matched with &gt;-1WAZ.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Brazil</arm_group_label>
    <description>Birth cohort study community in Brazil is urban, and located within the Papoco area of Fortaleza.
Case control study is being conducted in the same area as the cohort study. Cases are children 6 - 24 months of age, with &lt;-2 WAZ (weight for age) score, controls are age and community matched children with &gt;-1 WAZ.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>India</arm_group_label>
    <description>Birth cohort study community in India is urban, and located in the southern state of Tamil Nadu, specifically in Vellore.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nepal</arm_group_label>
    <description>Birth cohort study community in Nepal is semi-urban, and located in Bhaktapur, approximately 25km from Kathmandu.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pakistan</arm_group_label>
    <description>Birth cohort study community in Pakistan is rural, and located in Naushero Feroze, Sindh.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peru</arm_group_label>
    <description>Birth cohort study community in Peru is rural, and located approximately 15km from Iquitos in Loreto.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>South Africa</arm_group_label>
    <description>Birth cohort study community in South Africa is rural/peri-urban, and comprised of nine settlements within Limpopo Province.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tanzania</arm_group_label>
    <description>Birth cohort study community in Tanzania is rural, and located within Haydom.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma, stool, urine, saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population for the MAL-ED Project is a birth cohort. Pregnant women were
        identified from their communities, consented and the child will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Less than 17 days old.

        Exclusion Criteria:

          -  Mother is less than 16 years of age.

          -  Mother has another child inthe MAL-ED study.

          -  Pregnancy resulted in multiple birth (e.g., twins).

          -  Child has a severe disease requiring hospitalization for something other than for a
             typical healthy birth.

          -  Child has a severe or chronic condition diagnosed by a medical doctor (e.g., neonatal
             disease, renal disease, chronic heart failure, liver disease, cystic fibrosis,
             congenital conditions).

          -  Child has enteropathies diagnosed by medical doctor.

          -  Mother is living and unable to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Gottlieb, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fountation for the National Institutes of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roger Glass, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>NIH Fogarty International Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>International Centre for Diarrheal Disease Research, Bangladesh</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidade Federal do Cear√°</name>
      <address>
        <city>Fortaleza</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christian Medical College</name>
      <address>
        <city>Vellore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Medicine</name>
      <address>
        <city>Kathmandu</city>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aga Khan University</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JHSPH Satellite Laboratory</name>
      <address>
        <city>Iquitos</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Venda</name>
      <address>
        <city>Limpopo</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haydom Lutheran Hospital</name>
      <address>
        <city>Haydom</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
    <country>Brazil</country>
    <country>India</country>
    <country>Nepal</country>
    <country>Pakistan</country>
    <country>Peru</country>
    <country>South Africa</country>
    <country>Tanzania</country>
  </location_countries>
  <link>
    <url>http://mal-ed.fnih.org/</url>
    <description>MAL-ED Project website</description>
  </link>
  <link>
    <url>http://cid.oxfordjournals.org/content/59/suppl_4.toc</url>
    <description>&quot;The Malnutrition and Enteric Disease Study (MAL-ED): Understanding the Consequences for Child Health and Development: CID supplement V59 suppl4; 2014</description>
  </link>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2015</study_first_submitted>
  <study_first_submitted_qc>May 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <last_update_submitted>May 7, 2015</last_update_submitted>
  <last_update_submitted_qc>May 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cognitive development</keyword>
  <keyword>Diarrheal disease</keyword>
  <keyword>Enteric infections</keyword>
  <keyword>Malnutrition</keyword>
  <keyword>Vaccine Response</keyword>
  <keyword>Enteropathy</keyword>
  <keyword>Antibiotic use</keyword>
  <keyword>Micronutrients</keyword>
  <keyword>Breast feeding</keyword>
  <keyword>Gut inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

